Examinant per Autoria "Canales, M."
Mostrant 1 - 2 de 2
Resultats per pàgina
Opcions d'ordenació
Ítem Accés Obert Central nervous system prophylaxis with intrathecal liposomal cytarabine in a subset of high-risk patients with diffuse large B-cell lymphoma receiving first line systemic therapy in a prospective trial.(Springer Verlag, 2016) González-Barca, E.; Canales, M.; Salar Silvestre, Antonio; Ferreiro-Martínez, J. J.; Ferrer-Bordes, S.; García-Marco, J. A.; Sánchez-Blanco, J. J.; García-Frade, Javier; Peñalver, Francisco-Javier; Bello-López, J. L.; Sancho, José María; Caballero, Dolores; GELTAMO Group
Ítem Accés Obert Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular Llymphoma after first-line immunochemotherapy: results of the RBMDGELTAMO08 phase II trial(Wiley, 2019) Peñalver, Francisco-Javier; Márquez, José-Antonio; Durán, Soledad; Giraldo, Pilar; Martin, Alejandro; Montalbán, Carlos; Sancho, Juan Manuel; Ramírez, María-José; Terol, María-José; Capote, Francisco-Javier; Gutiérrez, Antonio; Sánchez González, Blanca; López, Andrés; Salar Silvestre, Antonio; Rodríguez-Caravaca, Gil; Canales, M.; Caballero, María Dolores; GELTAMO Group